Screening the interactions between HIV-1 neutralizing antibodies and model lipid surfaces

Alam, 2007, The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes, J. Immunol., 178, 4424, 10.4049/jimmunol.178.7.4424 Bures, 2000, Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1, AIDS Res. Hum. Retroviruses, 16, 2019, 10.1089/088922200750054756 Burton, 2004, HIV vaccine design and the neutralizing antibody problem, Nat. Immunol., 5, 233, 10.1038/ni0304-233 Conley, 1994, Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody, Proc. Natl. Acad. Sci. U. S. A., 91, 3348, 10.1073/pnas.91.8.3348 Cooper, 2004, Advances in membrane receptor screening and analysis, J. Mol. Recognit., 17, 286, 10.1002/jmr.675 Dubois, 1992, Synthesis, structure, and properties of model organic-surfaces, Annu. Rev. Phys. Chem., 43, 437, 10.1146/annurev.pc.43.100192.002253 Giles, 2005, The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin, Arthritis Res. Ther., 7, R47, 10.1186/ar1449 Hauser, 1981, Preferred conformation and molecular packing of phosphatidylethanolamine and phosphatidylcholine, Biochim Biophys Acta, 650, 21, 10.1016/0304-4157(81)90007-1 Haynes, 2005, Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies, Science, 308, 1906, 10.1126/science.1111781 Im, 2010, Membrane protein biosensing with plasmonic nanopore arrays and pore-spanning lipid membranes, Chem. Sci., 1, 688, 10.1039/c0sc00365d Liao, 2006, A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and CHIV-1 primary viruses, Virology, 353, 268, 10.1016/j.virol.2006.04.043 MacDonald, 1991, Small-volume extrusion apparatus for preparation of large, unilamellar vesicles, Biochim. Biophys. Acta, 1061, 297, 10.1016/0005-2736(91)90295-J Ofek, 2004, Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope, J. Virol., 78, 10724, 10.1128/JVI.78.19.10724-10737.2004 Sanchez-Martinez, 2006, Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody, FEBS Lett., 580, 2395, 10.1016/j.febslet.2006.03.067 Scearce, 1983, Production of monoclonal antibodies reacting with the cytoplasm and surface of differentiated cells, Methods Enzymol., 103, 459, 10.1016/S0076-6879(83)03032-3 Sun, 2008, HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane, Immunity, 28, 52, 10.1016/j.immuni.2007.11.018 Wiltschi, 2006, Binding assays with artificial tethered membranes using surface plasmon resonance, Methods, 39, 134, 10.1016/j.ymeth.2006.05.007 Zhu, 1999, Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies, Br. J. Haematol., 105, 102, 10.1111/j.1365-2141.1999.01292.x Zwick, 2001, Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41, J. Virol., 75, 10892, 10.1128/JVI.75.22.10892-10905.2001